Compare NOTV & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOTV | EQS |
|---|---|---|
| Founded | 1974 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 25.8M |
| IPO Year | 1997 | N/A |
| Metric | NOTV | EQS |
|---|---|---|
| Price | $0.70 | $1.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 5.3K |
| Earning Date | 02-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $513,024,000.00 | $1,377,000.00 |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $45.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.54 | ★ 21.11 |
| 52 Week Low | $0.66 | $0.74 |
| 52 Week High | $6.48 | $2.49 |
| Indicator | NOTV | EQS |
|---|---|---|
| Relative Strength Index (RSI) | 31.90 | 44.76 |
| Support Level | $0.79 | $1.64 |
| Resistance Level | $0.86 | $1.79 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 7.66 | 33.44 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.